Tuesday May 13 | XtraMSN Real Estate
Pharmacy fined following dispensing errors
“The errors that have occurred have been of great concern. "This was obviously not intended and we apologise for the distress and concern caused”
A pharmacy which mistakenly dispensed an anti-psychotic drug to a toddler has been fined $10,000 and had operational conditions imposed on it. via XtraMSN Real Estate
Thursday May 8 | MediLexicon
A new study, presented for the first time at an international psychiatric meeting, examined the time to relapse in patients with schizophrenia treated with risperidone long-acting injection or oral quetiapine. via MediLexicon
Tuesday May 6 | Earth Times
'CNS Generic Drugs: Prospects and Opportunities to 2012' Now Available
Research and Markets has announced the addition of CNS Generic Drugs: Prospects and Opportunities to 2012 to their offering. via Earth Times
Tuesday May 6 | Rehab Management
Patients Treated with Risperidone Long-Acting Injection had a...
“This study provides compelling evidence that RLAI offers a significant benefit to people with schizophrenia in delaying the time to relapse”
Today, data from a new international study showed that patients treated with risperidone long-acting injection had a significantly longer time to relapse compared to patients treated with an oral atypical ... via Rehab Management
Sunday Apr 20 | Nursing Center
This Article is provided free of charge. Med Watch OTC cough medicine questions arise The FDA issued a Public Health Advisory concerning the use of over-the-counter cough/cold products in children and its ... via Nursing Center
Friday Apr 18 | Med Ad News
Tier Status in Private Insurance Plans for Other Antipsychotic Drugs...
“For schizophrenia, bipolar disorder and major depression, psychiatrists will switch more Risperdal patients to generic risperidone than will PCPs”
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that when Janssen's Risperdal loses market exclusivity later this year in the United ... via Med Ad News
Apr 16, 2008 | MediLexicon
Supplemental New Drug Application For RISPERDAL(R) CONSTA(R)...
Alkermes, Inc. announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. , submitted a Supplemental New Drug Application for RISPERDAL CONSTA [ Long-Acting Injection] to the ... via MediLexicon
Apr 13, 2008 | Reuters
Court grants Teva generic Risperdal exclusivity
“We project Teva could record around $230 million (in sales) during its exclusivity period”
Teva Pharmaceutical Industries Ltd said on Friday a U.S. court granted a request that would give the Israeli company 180 days of exclusivity selling a generic version of widely used schizophrenia drug ... via Reuters
Apr 11, 2008 | Business Wire
Teva Receives Court Ruling Awarding Exclusivity for Generic Risperdal
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Columbia has granted a request of the Company's subsidiary, Teva Pharmaceuticals USA, Inc. via Business Wire
Apr 7, 2008 | BMC Surgery
Cost of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics -- olanzapine, quetiapine, or risperidone. via BMC Surgery







